Pharmaceutical Technology presents

Solubilisation and Stability of Drug Actives
10th December, 1:00pm GMT, 2:00pm CET
» Register Free Here

Event Overview:


There continues to be challenges with API stability and solubilisation enhancement for the pharmaceutical formulator. Some of these issues can be addressed with Croda's high purity excipient solutions.

During this e-seminar, challenges involving excipient purity, oxidation and API stability will be discussed and the excipient focus will include polysorbates, polyethylene glycols and dimethyl isosorbide. This presentation is designed to provide some useful insights for choosing the most appropriate excipient and will highlight Croda's solutions.

Key Learning Objectives:

  • Recognise Croda as a premier supplier of high purity excipients
  • Understand the benefits of Super Refining technology
  • Be aware of the negative effects of excipient impurities on API stability
  • Highlight Croda's product offerings in this area
    • Super Refined™ Polar excipients (such as PEGs, Polysorbates and Dimethyl Isosorbide)
    • Super Refined™ Non-Polar excipients (such as Sesame, Soybean and other oils)
Who Should Attend:
» Formulators
» R&D
» Drug Discovery
»   Contract Research Organisations
»   Contract Manufacturer Organisations
»   Senior Management

Moderator
Fedra Pavlou Fedra Pavlou
Editor in Chief
Pharmaceutical Technology Europe

Speakers:
George J. Rizzo George J. Rizzo
Health Care Research Team Leader-Technical Applications & Product Development

Karen H. Chen Karen H. Chen
Health Care Marketing Manager